Protocol 156-08-275 - A Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Sub

Project: Other project

StatusFinished
Effective start/end date10/1/104/30/14

Funding

  • Covance Incorporated: $10,240.00